To verify this hypothesis we treated tumour-bearing rats for two weeks with celecoxib to determine if the treatment was able to reduce the percentage of cells with putative stemness features which we considered those expressing both LGR-5 and nuclear β-catenin. Here, LGR5 is linked to neoplasm.